---
figid: PMC4726830__jbr-30-01-019-g003
figtitle: Emerging targets for glioblastoma stem cell therapy
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Sus scrofa
- clinical samples
- Callanthias legras
organisms_ner:
- Mus musculus
- Sus scrofa
- Homo sapiens
- Rattus norvegicus
- Drosophila melanogaster
pmcid: PMC4726830
filename: jbr-30-01-019-g003.jpg
figlink: /pmc/articles/PMC4726830/figure/f03/
number: F3
caption: A complex signaling pathway governs self-renewal, stemness, and maintenance
  of CSGs. Proteins in these pivotal cellular pathways including several plasma membrane
  receptors, cytoplasmic signaling proteins, specific transcription factors, growth
  factors, and ligands have the potential to be targeted for eradicating GSCs.
papertitle: Emerging targets for glioblastoma stem cell therapy.
reftext: Ahmad R. Safa, et al. J Biomed Res. 2016 Jan;30(1):19-31.
year: '2016'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9622223
figid_alias: PMC4726830__F3
figtype: Figure
redirect_from: /figures/PMC4726830__F3
ndex: 75698e4c-deda-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4726830__jbr-30-01-019-g003.html
  '@type': Dataset
  description: A complex signaling pathway governs self-renewal, stemness, and maintenance
    of CSGs. Proteins in these pivotal cellular pathways including several plasma
    membrane receptors, cytoplasmic signaling proteins, specific transcription factors,
    growth factors, and ligands have the potential to be targeted for eradicating
    GSCs.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Grb2
  - Hspg2
  - ras
  - Hras
  - Kras
  - Rem1
  - Pten
  - Src
  - Pik3r1
  - Zhx2
  - Mtor
  - Mlst8
  - Slc12a3
  - Tsc22d1
  - Mdk
  - Rptor
  - Rictor
  - Ephb2
  - Mapk1
  - Melk
  - Jun
  - GRB2
  - PTEN
  - SRC
  - PKC
  - FYN
  - PRKCH
  - PRKD1
  - PRKCI
  - PRKCB
  - MTOR
  - MLST8
  - RICTOR
  - MELK
  - JUN
  - ANGPT1
  - ANGPT2
  - ANGPT4
  - AREG
  - BDNF
  - CSF1
  - EFNA1
  - EFNA2
  - EFNA3
  - EFNA4
  - EFNA5
  - EGF
  - EREG
  - FGF1
  - FGF10
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF2
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FLT3LG
  - HGF
  - IGF1
  - IGF2
  - INS
  - KITLG
  - NGF
  - NTF3
  - NTF4
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - PGF
  - TGFA
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - XYLT2
  - SOS1
  - SOS2
  - HSPG2
  - PLCE1
  - PLCZ1
  - PLCB1
  - PLCB2
  - PLCB3
  - PLCB4
  - PLCD1
  - PLCD3
  - PLCD4
  - PLCG1
  - PLCG2
  - KRAS
  - HRAS
  - NRAS
  - FGR
  - YES1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - PRRT2
  - PRKCA
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCQ
  - PRKCZ
  - PRKD3
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - SLC12A3
  - TSC1
  - TESC
  - TSC2
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - EPHB2
  - MAPK1
  - MAPK3
  - MAPKAP1
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - Pik3cg
  - Prkcg
  - Ephb1
  - Ccne1
  - drk
  - Sos
  - norpA
  - sl
  - Plc21C
  - Ras64B
  - Ras85D
  - Src42A
  - Csk
  - Src64B
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - inaC
  - Pkc98E
  - aPKC
  - Pkc53E
  - Raf
  - Tor
  - Tsc
  - Tsc1
  - Dsor1
  - Mtk
  - raptor
  - rictor
  - Erk7
  - rl
  - MKP-4
  - p38b
  - Jra
  - CycE
  - cyc
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
